Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel

Division of GEIS Operations, Armed Forces Health Surveillance Center, Silver Spring, Maryland, United States of America.
PLoS ONE (Impact Factor: 3.53). 05/2010; 5(5):e10722. DOI: 10.1371/journal.pone.0010722
Source: PubMed

ABSTRACT A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available.
Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%).
A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.

Download full-text


Available from: Robert DeFraites, Jul 27, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The operation of an effective wireless sensor network requires energy awareness. This paper focuses on the development of the autonomous node selection (ANS) algorithm as a means to conserve energy. The algorithm provides a protocol for a resource manager to conserve energy as a network of bearings-only sensors track a target in a decentralized manner. Specifically, each node within radio range of the active nodes uses the predicted target location to determine whether or not to actively measure and communicate bearing reports. The goal of ANS is to conserve energy by limiting communications while optimizing the geolocation performance of the tracker. Using derived bounds on the usefulness of nodes, the ANS method also conserves energy by limiting the transmission distance on the radios of the active nodes. As a result, nodes too far from the target to be useful can remain in a sleep mode. Once the target moves close enough to these nodes, they will receive transmissions from the active nodes and decide whether or not to actively sense and communicate. Simulations demonstrate the tradeoffs between geolocation performance and energy conservation when implementing different parameterizations of the ANS algorithm.
    Aerospace Conference, 2004. Proceedings. 2004 IEEE; 04/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We conducted a prospective household transmission study to examine whether receipt of 2009 trivalent influenza vaccine (TIV) was associated with increased risk of influenza-like illness (ILI) among contacts of confirmed pandemic influenza A(H1N1) 2009 patients. In the week following onset of pandemic illness in a household member, 46 (15%) of 304 TIV-vaccinated contacts, and 174 (15%) of 1,162 unvaccinated contacts developed ILI (p=0.95). Receipt of 2009 TIV had no effect on one's risk of pandemic illness.
    Eurosurveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 01/2010; 15(28). · 4.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An analytic gradient expression is formulated and implemented for the second-order Møller-Plesset perturbation theory (MP2) based on the generalized hybrid orbital QM/MM method. The method enables us to obtain an accurate geometry at a reasonable computational cost. The performance of the method is assessed for various isomers of alanine dipepetide. We also compare the optimized structures of fumaramide-derived [2]rotaxane and cAMP-dependent protein kinase with experiment.
    The Journal of Chemical Physics 02/2010; 132(8):084106. DOI:10.1063/1.3329370 · 3.12 Impact Factor
Show more